The Colombian-American manufacturer of architectural glass and windows posted adjusted earnings of $1.03 a share, above Wall ...

Shares of TG Therapeutics slumped after the company's second-quarter profit missed analyst estimates. The stock was down 17% at $29.22 in early trading. Shares are now 3% lower than where they had ...

That was accompanied by a double-digit improvement in revenue.

TG Therapeutics missed Q2 earnings and revenue expectations but raised its 2025 Briumvi sales guidance following strong global growth.

Given whey's price stability, rising nutrition consumer prices and its business model, THG expects second-half revenue growth for its nutrition division of between 10% and 12%. It expects a group ...

TG Therapeutics stock crashed Monday after the drugmaker reported in-line sales of Briumvi, but missed second-quarter profit ...

What Is the Price of Bitcoin Today? Bitcoin (BTC) traded at $113,879 as of 9:21 a.m. ET. That's down 0.25% over the past 24 hours and up 20.61% year to date. The original crypto’s 52-week ...

Fertilizer Prices and Farmer Profitability: Best Case Scenario Prices Flatten, But Won’t Go Down Fertilizer prices have been on a steady climb, despite grain prices continuing to lag.

Figma just went public and could be the biggest IPO of the year. Here's what you need to know.